Intralesional Injection of STS in Treatment of Calcinosis
Intralesional Injection of STS in Treatment of Calcinosis
Recruiting · NCT06672822 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intralesional Injection of STS in Treatment of Calcinosis | Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, calcinosis, calcium metabolic disease, connective tissue disorder, dermatomyositis, metabolic disease, mixed connective tissue disease, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-05-05 | NCT06672822 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 108 |
| Robyn T. Domsic, MD, MPH | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UPMC Arthritis and Autoimmunity Center | Pittsburgh | United States | 1 |